Elitza S. Theel, Ph.D., D(ABMM)
Mayo Clinic
Elitza (Elli) S. Theel, Ph.D., D(ABMM), is director of the Infectious Diseases Serology Laboratory and co-director of the Vector-Borne Diseases Service Line at Mayo Clinic in Rochester, Minn. She is associate professor of laboratory medicine and pathology at Mayo Clinic, and is the program director for the Clinical °®¶¹´«Ã½ CPEP progam.
Theel received her Ph.D. in medical microbiology and immunology at the University of Wisconsin-Madison, and subsequently completed a clinical microbiology fellowship at Mayo Clinic. She is certified by the American Board of Medical °®¶¹´«Ã½. She is a member of the editorial board for multiple journals, including the and Clinical Infectious Diseases. Theel serves on the CAP °®¶¹´«Ã½ Resource Committee and the APHL/CDC working group for standardization of reporting language for Lyme disease serologic testing.
Her research interests revolve around the evaluation and development of serologic assays for vector-borne diseases and fungal pathogens. Finally, she also spearheads a philanthropic, international laboratory outreach initiative in Belize, focused on increasing the in-country testing capacity for vector-borne diseases, establishing seroprevalence rates for these pathogens and enhancing the quality assurance/quality control practices in clinical laboratories throughout the country.
Theel received her Ph.D. in medical microbiology and immunology at the University of Wisconsin-Madison, and subsequently completed a clinical microbiology fellowship at Mayo Clinic. She is certified by the American Board of Medical °®¶¹´«Ã½. She is a member of the editorial board for multiple journals, including the and Clinical Infectious Diseases. Theel serves on the CAP °®¶¹´«Ã½ Resource Committee and the APHL/CDC working group for standardization of reporting language for Lyme disease serologic testing.
Her research interests revolve around the evaluation and development of serologic assays for vector-borne diseases and fungal pathogens. Finally, she also spearheads a philanthropic, international laboratory outreach initiative in Belize, focused on increasing the in-country testing capacity for vector-borne diseases, establishing seroprevalence rates for these pathogens and enhancing the quality assurance/quality control practices in clinical laboratories throughout the country.